» Articles » PMID: 28736490

Electromagnetic Transduction Therapy in Non-specific Low Back Pain: A Prospective Randomised Controlled Trial

Overview
Journal J Orthop
Specialty Orthopedics
Date 2017 Jul 25
PMID 28736490
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: A prospective randomised controlled trial to investigate the efficacy of electromagnetic transduction therapy (EMTT) for treatment of patients with non-specific low back pain.

Design: Two groups with non-specific low back pain were either treated with conventional therapy alone over 6 weeks or in combination with 8 sessions of EMTT.

Results: In both intervention groups the low back pain related pain and the degree of disability decreased significantly at follow-up visits. Combination of EMTT and conventional therapy proved significant superior to conventional therapy alone.

Conclusion: EMTT is a promising treatment in patients with non-specific low back pain.

Citing Articles

Effectiveness of Electromagnetic Field Therapy in Mechanical Low Back Pain: A Randomized Controlled Trial.

Koura G, Elshiwi A, Alshahrani M, Elimy D, Alshahrani R, Alfaya F J Pain Res. 2025; 18:1131-1142.

PMID: 40078750 PMC: 11900790. DOI: 10.2147/JPR.S500698.


Extracorporeal Magnetotransduction Therapy as a New Form of Electromagnetic Wave Therapy: From Gene Upregulation to Accelerated Matrix Mineralization in Bone Healing.

Gerdesmeyer L, Tubel J, Obermeier A, Harrasser N, Glowalla C, von Eisenhart-Rothe R Biomedicines. 2024; 12(10).

PMID: 39457582 PMC: 11505246. DOI: 10.3390/biomedicines12102269.


Efficacy of pulsed electromagnetic field therapy on pain and physical function in patients with non-specific low back pain: a systematic review.

Kull P, Keilani M, Remer F, Crevenna R Wien Med Wochenschr. 2023; 175(1-2):11-19.

PMID: 37999784 PMC: 11775040. DOI: 10.1007/s10354-023-01025-5.


Between guidelines and clinical trials: evidence-based advice on the pharmacological management of non-specific chronic low back pain.

Migliorini F, Vaishya R, Pappalardo G, Schneider M, Bell A, Maffulli N BMC Musculoskelet Disord. 2023; 24(1):432.

PMID: 37254090 PMC: 10228138. DOI: 10.1186/s12891-023-06537-0.


Choosing the appropriate pharmacotherapy for nonspecific chronic low back pain.

Migliorini F, Maffulli N J Orthop Surg Res. 2022; 17(1):556.

PMID: 36544200 PMC: 9773490. DOI: 10.1186/s13018-022-03426-5.


References
1.
van Tulder M, Koes B, Bombardier C . Low back pain. Best Pract Res Clin Rheumatol. 2002; 16(5):761-75. DOI: 10.1053/berh.2002.0267. View

2.
van Tulder M, Becker A, Bekkering T, Breen A, Gil Del Real M, Hutchinson A . Chapter 3. European guidelines for the management of acute nonspecific low back pain in primary care. Eur Spine J. 2006; 15 Suppl 2:S169-91. PMC: 3454540. DOI: 10.1007/s00586-006-1071-2. View

3.
Gerdesmeyer L, Lampe R, Veihelmann A, Burgkart R, Gobel M, Gollwitzer H . [Chronic radiculopathy. Use of minimally invasive percutaneous epidural neurolysis according to Racz]. Schmerz. 2004; 19(4):285-95. DOI: 10.1007/s00482-004-0371-x. View

4.
Paungmali A, Henry L, Sitilertpisan P, Pirunsan U, Uthaikhup S . Improvements in tissue blood flow and lumbopelvic stability after lumbopelvic core stabilization training in patients with chronic non-specific low back pain. J Phys Ther Sci. 2016; 28(2):635-40. PMC: 4793024. DOI: 10.1589/jpts.28.635. View

5.
Carvalho C, Caetano J, Cunha L, Rebouta P, Kaptchuk T, Kirsch I . Open-label placebo treatment in chronic low back pain: a randomized controlled trial. Pain. 2016; 157(12):2766-2772. PMC: 5113234. DOI: 10.1097/j.pain.0000000000000700. View